Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q2 EPS of ($0.45), $0.29 better than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.